Narrative review / 2015
Evidence suggests vitamin D may modify immune responses in IBD, with emerging trial data hinting at longer remission periods.
This review evaluates scientific evidence regarding vitamin D and inflammation, focusing primarily on inflammatory bowel disease (IBD). Suboptimal vitamin D status is common in IBD, and some studies suggest it associates with more severe disease. Early data from randomized controlled trials suggest that people with IBD may remain in remission longer when treated with oral vitamin D, though large, well-designed clinical trials are still needed.
- Study type
- Narrative review
- Who was studied
- People with inflammatory bowel disease (IBD)
- What was measured
- Inflammation, disease severity, and maintenance of remission in IBD
THE PAPER
Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn?
O'Sullivan M. Proc Nutr Soc, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.